Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.

van Eupen MG, Schram MT, Colhoun HM, Scheijen JL, Stehouwer CD, Schalkwijk CG.

Cardiovasc Diabetol. 2013 Oct 17;12:149. doi: 10.1186/1475-2840-12-149.

2.

Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.

Lieuw-A-Fa ML, van Hinsbergh VW, Teerlink T, Barto R, Twisk J, Stehouwer CD, Schalkwijk CG.

Nephrol Dial Transplant. 2004 Mar;19(3):631-6.

3.

The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.

van Eupen MG, Schram MT, Colhoun HM, Hanssen NM, Niessen HW, Tarnow L, Parving HH, Rossing P, Stehouwer CD, Schalkwijk CG.

Diabetologia. 2013 Aug;56(8):1845-55. doi: 10.1007/s00125-013-2919-8. Epub 2013 Apr 26.

PMID:
23620061
4.
5.

Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.

Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, Schalkwijk CG.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1369-73. doi: 10.1210/jc.2013-1068. Epub 2013 Jun 18.

PMID:
23780372
6.

Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.

Gopal P, Reynaert NL, Scheijen JL, Engelen L, Schalkwijk CG, Franssen FM, Wouters EF, Rutten EP.

Eur Respir J. 2014 Feb;43(2):430-8. doi: 10.1183/09031936.00135312. Epub 2013 May 3.

7.

Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.

Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S; DCCT/EDIC Research Group.

Cardiovasc Diabetol. 2015 Sep 5;14:118. doi: 10.1186/s12933-015-0266-4. Erratum in: Cardiovasc Diabetol. 2015;14:138.

8.

Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.

Nur E, Brandjes DP, Schnog JJ, Otten HM, Fijnvandraat K, Schalkwijk CG, Biemond BJ; CURAMA Study Group.

Br J Haematol. 2010 Oct;151(1):62-9. doi: 10.1111/j.1365-2141.2010.08320.x. Epub 2010 Jul 30.

PMID:
20678158
9.

Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.

Piroddi M, Palazzetti I, Quintaliani G, Pilolli F, Montaldi M, Valentina V, Libetta C, Galli F.

J Ren Nutr. 2011 Jul;21(4):329-39. doi: 10.1053/j.jrn.2010.06.024. Epub 2010 Dec 30.

PMID:
21193322
10.

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

Miura J, Yamagishi Si, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y.

J Diabetes Complications. 2003 Jan-Feb;17(1):16-21.

PMID:
12505751
11.

Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.

Kerkeni M, Weiss IS, Jaisson S, Dandana A, Addad F, Gillery P, Hammami M.

Thromb Res. 2014 Sep;134(3):633-8. doi: 10.1016/j.thromres.2014.07.008. Epub 2014 Jul 17.

PMID:
25065554
12.

Protein-Bound Plasma Nε-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies.

Gaens KH, Ferreira I, van de Waarenburg MP, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Rensen SS, Stehouwer CD, Schalkwijk CG.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2707-13. doi: 10.1161/ATVBAHA.115.306106. Epub 2015 Oct 8.

PMID:
26449750
13.

High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.

Neumann T, Lodes S, Kästner B, Franke S, Kiehntopf M, Lehmann T, Müller UA, Wolf G, Sämann A.

Osteoporos Int. 2014 May;25(5):1527-33. doi: 10.1007/s00198-014-2631-7. Epub 2014 Mar 6.

PMID:
24599273
14.

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.

Suliman ME, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi AR, Bárány P, Heimbürger O, Lindholm B.

Clin Nephrol. 2006 Dec;66(6):418-25.

PMID:
17176913
15.

Advanced glycation end products in children with chronic renal failure and type 1 diabetes.

Misselwitz J, Franke S, Kauf E, John U, Stein G.

Pediatr Nephrol. 2002 May;17(5):316-21.

PMID:
12042886
16.

Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.

Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ.

J Card Fail. 2008 Sep;14(7):596-602. doi: 10.1016/j.cardfail.2008.03.008. Epub 2008 May 27.

PMID:
18722326
17.

Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.

de Groot L, Hinkema H, Westra J, Smit AJ, Kallenberg CG, Bijl M, Posthumus MD.

Arthritis Res Ther. 2011;13(6):R205. doi: 10.1186/ar3538. Epub 2011 Dec 14.

18.

Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients.

Taki K, Takayama F, Tsuruta Y, Niwa T.

Kidney Int. 2006 Jul;70(1):218-24. Epub 2006 May 24.

19.

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.

Willemsen S, Hartog JW, van Veldhuisen DJ, van der Meer P, Roze JF, Jaarsma T, Schalkwijk C, van der Horst IC, Hillege HL, Voors AA.

Am Heart J. 2012 Nov;164(5):742-749.e3. doi: 10.1016/j.ahj.2012.07.027.

PMID:
23137505
20.

Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.

Ghanem AA, Elewa A, Arafa LF.

Eur J Ophthalmol. 2011 Jan-Feb;21(1):48-54.

PMID:
20544678
Items per page

Supplemental Content

Write to the Help Desk